Skip to main navigation Skip to search Skip to main content

Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer

  • Mankil Jung
  • , Sangmin Lee
  • , Jungyeob Ham
  • , Kyunghoon Lee
  • , Hanjo Kim
  • , Soo Kie Kim
  • Yonsei University
  • Yonsei University Mirae Campus

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Abstract

The first primary amines 9 and bromoalkyl analogues 7 of deoxoartemisinin with nonacetal functionality at C-12 are prepared as versatile intermediates for the synthesis of various derivatives. Eight C-12 nonacetal type dimers and one trimer of deoxoartemisinin were prepared using novel chemistry. Dimers, particularly 12a, 18a,b, and trimer 17, were especially potent and selective at inhibiting the growth of certain human cancer cell lines and were comparable to that of clinically used anticancer drugs. The linker with one amide- or one sulfur-centered two ethylene groups of the dimers is essential for high anticancer activity. Trimer 17 shows very potent activity against most of the human cancer cell lines tested.

Original languageEnglish
Pages (from-to)987-994
Number of pages8
JournalJournal of Medicinal Chemistry
Volume46
Issue number6
DOIs
StatePublished - 13 Mar 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer'. Together they form a unique fingerprint.

Cite this